Cat. No.: X24-08-YM066
Topoisomerase inhibitor, Edotecarin, Purity ≥98%
Synonym: 174402-32-5; J 107088; PF 804950; 13-(1,3-Dihydroxypropan-2-ylamino)-6,20-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione
- CAS Number: 174402-32-5
- Compound CID: 9808998
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Properties
Description
Edotecarin is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting topoisomerase. It targets the protein kinase C and topoisomerase I.
Molecular Formula
C29H28N4O11
Targets
Protein kinase C: 160 μM (IC50); Topoisomerase I: 50 nM (IC50)
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Edotecarin is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of solid tumors.
Storage
Store at -20ºC, and keep desiccated.
Related Products
- Topoisomerase inhibitor, ABT-492, Purity ≥98%
- Topoisomerase inhibitor, Amonafide, Purity ≥98%
- Topoisomerase inhibitor, Camptothecin, Purity ≥98%
- Topoisomerase inhibitor, Gatifloxacin, Purity ≥98%
- Topoisomerase inhibitor, Idarubicin HCl, Purity ≥98%
- Topoisomerase inhibitor, Irinotecan, Purity ≥98%
